Company Filing History:
1 out of 78 
1 out of 1 Years Active: 2018
Title: David Paul D Woldbye: Innovator in Neuroprotective Peptides
Introduction: David Paul D Woldbye is a distinguished inventor based in Copenhagen, Denmark, known for his groundbreaking work in the field of neuropeptide research. With a focus on neuroprotection and neuroplasticity, his contributions have significant implications for medical treatments relating to brain and retina disorders.
Latest Patents: Woldbye holds a patent for his invention titled "Neuropeptide Y-derived peptides." This innovative patent discloses peptide fragments derived from neuropeptide Y (NPY), capable of selectively binding to the neural cell adhesion molecule (NCAM). These peptide fragments induce neuroplastic and neuroprotective effects, presenting great potential as neuritogenic agents for treating various pathological conditions.
Career Highlights: David Paul D Woldbye has made significant strides in his professional career, particularly as a researcher affiliated with the University of Copenhagen and Næstved Hospital. His academic and clinical collaborations have played a critical role in advancing his inventions and discoveries.
Collaborations: Throughout his career, Woldbye has collaborated with notable colleagues such as Casper Rene Gøtzsche and Kristian Klemp. These collaborations indicate a strong network of professionals committed to advancing scientific understanding and innovation in neurobiology.
Conclusion: David Paul D Woldbye's contributions to the field of neuropeptide research exemplify the impact of innovation and invention in addressing complex medical challenges. His patent on neuropeptide Y-derived peptides stands as a testament to his expertise and dedication to improving therapeutics for neurological disorders. The ongoing exploration of his findings is likely to influence future research and treatment strategies, showcasing the essential role inventors play in transforming scientific knowledge into practical solutions.